[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-PPH2)-TICL-(MY-CL)]-RUCL]-(BF4)
Compound with spectra: 1 NMR
![[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-PPH2)-TICL-(MY-CL)]-RUCL]-(BF4)](/api/compound/Ifpt7c4DkpB.png?ph=true&h=300&w=458 "[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-PPH2)-TICL-(MY-CL)]-RUCL]-(BF4)")
| SpectraBase Compound ID | Ifpt7c4DkpB |
|---|---|
| InChI | InChI=1S/C17H13P.C10H13.C5H3.BF4.3ClH.Ru.Ti/c1-3-9-15(10-4-1)18(17-13-7-8-14-17)16-11-5-2-6-12-16;1-8(2)10-6-4-9(3)5-7-10;1-2-4-5-3-1;2-1(3,4)5;;;;;/h1-13H;4,6-8H,1-3H3;1-2,5H;;3*1H;;/q;;;-1;;;;2*+1/p-1 |
| InChIKey | ZYEZWTHYMYCDJN-UHFFFAOYSA-M |
| Mol Weight | 787.7 g/mol |
| Molecular Formula | C32H30BCl3F4PRuTi |
| Exact Mass | 786.97027 g/mol |
| Parent InChIKey | JWGGMCWCYBYDAX-UHFFFAOYSA-M |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD2Cl2 |
Dispiro[piperidine-4,2'-[7,14,24,31]tetraoxapentacyclo[30.2.2.23,6.215,18.220,23]dotetraconta[3,5,15,17,20,22,32,34,35,37,39,41]dodecaen e-19',4''-piperidine], 1,1''-diacetyl-5',33'-dibromo-16',22',36',37',40',41'-hexamethyl-
tetramethyl (2.alpha.,3.alpha.,6.beta.,8.beta.,10.beta.,12.beta.,15.alpha.,16.alpha.)-19-endo,23-endo,27-exo-9,21-dioxo-7,11,19,23,27,28-hexaoxaundecacyclo[15.7.2.1(2,16),1(4,14).0(1,17).0(3,15).0(5,13).0(6,8).0(10,12).0(18,20).0(22,24)]octacosa-5(13),25-diene-3,15,25,26-tetracarboxylate
Quamoclin I peracetate [(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
Diethyl 4,4''-{[(1R,2R)-cyclohexane-1,2-diyl]dinitrilo-3,3,3',3'-tetramethyl-4,4'-[(2",3",7",8"-tetrahydro-2",2",3",3",7",7",8',8'-octamethyl-11"H-dipyrrin-1",9"-diylidene)-dinitrilo]-bis[butanoato](1-)cobalt(III)
Dimethyl 3,3'-[8"-(1'"-benzoyloxy-4"'-hydroxybut-1'"-yl)-2",7",12",18"-tetramethyl-2",3"-dihydro-21H.23H-porphyrin-13",17"-diyl]-dipropionate
(1R,5R,7S,8S,9S,10R)-1-[(2R*,5S)-5-[(2R,5R,6S)-5-benzyloxy-5-ethyl-6-methyltetrahydropyran-2-yl]-2-methoxy-5-methyltetrahydrofuran-2-yl]-9-ethyl-8,10-isopropylidenedioxy-1-(4-methoxybenzyloxy)-5,7-dimethyldodeca-2-yn-4-one
Quamoclin II peracetate[(S)-Convolvulinoic acid 11-O.beta,-D-glucopyranosyl-(1-3)-O-[4-O-2(S)-methylbutyryl-.alpha.,L-rhamnopyranosyl-(1-4)]-O-(2-O-n-dodececanoyl).alpha.,L-rhamnopyranosyl-(1-4)-O-.alpha.-L-rhymnopyranosyl[-(1-2)-.beta.D-fucopyranoside peracetate]
Laminat VII31-0164+HX+DMP 30
(1R,5R,7S,8S,9S,10R)-1-[(2R*,5S)-5-[(2R,5R,6S)-5-benzyloxy-5-ethyl-6-methyltetrahydropyran-2-yl]-2-methoxy-5-methyltetrahydrofuran-2-yl]-9-ethyl-8,10-isopropylidenedioxy-1-(4-methoxybenzyloxy)-5,7-dimethyldodeca-2-en-4-ol
(2R,3R,4S,6E,8R,9S,10S,11R,12R,13R)-1-tert-Butyldimethylsilyloxy-2,4,6,8,10,12-hexamethyl-3-(3,4-dimethoxybenzyloxy)-9,11-isopropylidenedioxy-13-(4-methoxybenzyloxy)-12-methoxymethoxypentacec-6-en-5-one
| Title | Journal or Book | Year |
|---|---|---|
| Development of Bimetallic Titanocene−Ruthenium−Arene Complexes As Anticancer Agents: Relationships between Structural and Biological Properties | Journal of Medicinal Chemistry | 2010 |